Overview
Brendan Mcnulty is a Hematologist Oncology specialist and a Hematologist in Garner, North Carolina. Dr. Mcnulty is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Anal Cancer, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Mcnulty is currently accepting new patients.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
300 Health Park Dr, Suite 220, Garner, NC 27529
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Duke Cancer Center
Scott Antonia is an Oncologist in Durham, North Carolina. Dr. Antonia has been practicing medicine for over 36 years and is rated as an Elite provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
Duke Cancer Center
I am a part of the thoracic oncology program. I work with patients who have cancers of the lung, which includes non-small cell lung cancer, small cell lung cancer, and mesothelioma. My focus is on clinical care, clinical trials, and developing new therapies for these diseases. When I first meet with a patient, I want them to understand what their diagnosis is, because there are actually multiple diagnoses of lung cancer and each are treated differently. Then I discuss with a patient whether they are a candidate for therapies such as molecular therapy or immunotherapy, and make sure they have a clear understanding of the treatment plan. There are some very promising new therapies for these diseases and we are fortunate to have those available to patients here at Duke. That’s one of the unique things we offer as an academic medical center. Dr. Stinchcombe is rated as an Elite provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Gamma Knife Radiosurgery.
Duke Cancer Center
I realized during a biology class in college that I could use my interest in science to help make a difference in people’s lives. It drove my decision to pursue a career in medicine. I realized early in medical school that I wanted to spend my career trying to understand cancer, how to fight it and caring for patients who have it. As a medical oncologist with Duke Cancer Center, I specialize in cancers of the chest, including lung cancer and mesothelioma. Working closely with my patients, getting to know them personally and understanding their values and goals, allows me to develop individualized care and treatment plans for each one. The most rewarding part of my work is developing long term relationships with my patients and their families throughout their cancer journeys. I am motivated and inspired by how my patients live their lives everyday. Dr. Melson is rated as an Elite provider by MediFind in the treatment of Mesothelioma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Anal CancerDr. Mcnulty isDistinguished. Learn about Anal Cancer.
- AnemiaDr. Mcnulty isDistinguished. Learn about Anemia.
- AngiosarcomaDr. Mcnulty isDistinguished. Learn about Angiosarcoma.
- Colorectal CancerDr. Mcnulty isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Mcnulty isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Mcnulty isDistinguished. Learn about Familial Pancreatic Cancer.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Breast CancerDr. Mcnulty isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency AnemiaDr. Mcnulty isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Chronic Lymphocytic Leukemia (CLL)Dr. Mcnulty isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- EGFR Positive Lung CancerDr. Mcnulty isAdvanced. Learn about EGFR Positive Lung Cancer.
- Essential ThrombocythemiaDr. Mcnulty isAdvanced. Learn about Essential Thrombocythemia.
- Experienced
- Acute Mountain SicknessDr. Mcnulty isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Mcnulty isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Mcnulty isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Mcnulty isExperienced. Learn about Adult Soft Tissue Sarcoma.

